Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
BRAINSTORM CELL THERAPEUTICS INC. | Chief Medical Officer | Common Stock | 66.8K | $15.2K | $0.23 | Jan 1, 2025 | Direct |
BRAINSTORM CELL THERAPEUTICS INC. | Chief Medical Officer | Common Stock | 10.7K | $2.43K | $0.23 | Jan 1, 2025 | By the Reporting Person's Roth IRA |
BRAINSTORM CELL THERAPEUTICS INC. | Chief Medical Officer | Common Stock | 2K | $456 | $0.23 | Jan 1, 2025 | Indirect |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
BCLI | BRAINSTORM CELL THERAPEUTICS INC. | Jan 1, 2025 | 1 | $0 | 4 | Jan 7, 2025 | Chief Medical Officer |
BCLI | BRAINSTORM CELL THERAPEUTICS INC. | Jul 19, 2024 | 1 | -$22.1K | 4 | Jul 24, 2024 | Chief Medical Officer |
BCLI | BRAINSTORM CELL THERAPEUTICS INC. | Apr 17, 2024 | 0 | $0 | 3/A | Jan 7, 2025 | Chief Medical Officer |